NC

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.5B
AUM Growth
+$94.9M
Cap. Flow
-$25.6M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.03%
Holding
225
New
17
Increased
85
Reduced
77
Closed
10
Avg Time Held
2.2 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$35.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$21M
3
KDP icon
Keurig Dr Pepper
KDP
+$20.3M
4
EFX icon
Equifax
EFX
+$17.3M
5
EWBC icon
East-West Bancorp
EWBC
+$13.4M

Top Sells

Rank Stock Value
1
DVA icon
DaVita
DVA
+$42.1M
2
GWW icon
W.W. Grainger
GWW
+$41.1M
3
ABBV icon
AbbVie
ABBV
+$35.2M
4
SWKS icon
Skyworks Solutions
SWKS
+$25.8M
5
PNRA
Panera Bread Co
PNRA
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 21.03%
2 Technology 17.98%
3 Financials 15.03%
4 Industrials 14.79%
5 Consumer Discretionary 13.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LKQ icon
1
LKQ Corp
LKQ
$5.52B
$109M 2.42%
3,299,752
-185
-0% -$5.72K
2013 Q2
16 quarters
TMO icon
2
Thermo Fisher Scientific
TMO
$249B
$104M 2.31%
594,944
+1,540
+0.3% +$259K
2013 Q2
16 quarters
SCHW icon
3
Charles Schwab
SCHW
$167B
$103M 2.28%
2,389,200
+3,045
+0.1% +$122K
2016 Q3
3 quarters
SNA icon
4
Snap-on
SNA
$18.8B
$97.5M 2.17%
617,160
+12,055
+2% +$1.97M
2013 Q2
16 quarters
WBA icon
5
DELISTED
Walgreens Boots Alliance
WBA
$93.6M 2.08%
1,195,070
-50,195
-4% -$4.13M
2013 Q2
16 quarters
AON icon
6
Aon
AON
$58.4B
$92.5M 2.06%
695,585
– –
2013 Q2
16 quarters
MA icon
7
Mastercard
MA
$528B
$91.7M 2.04%
755,430
+2,200
+0.3% +$261K
2013 Q2
16 quarters
AMG icon
8
Affiliated Managers Group
AMG
$9.62B
$88.5M 1.97%
533,475
+17,725
+3% +$2.83M
2013 Q2
16 quarters
MSFT icon
9
Microsoft
MSFT
$3.96T
$83.5M 1.86%
1,211,107
-60,165
-5% -$4.13M
2013 Q2
16 quarters
CSCO icon
10
Cisco
CSCO
$448B
$83.4M 1.86%
2,666,120
+184,860
+7% +$6.02M
2016 Q3
3 quarters
CBRE icon
11
CBRE Group
CBRE
$37.3B
$81.3M 1.81%
2,234,080
– –
2013 Q2
16 quarters
BALL icon
12
Ball Corp
BALL
$16B
$74.5M 1.66%
1,764,922
– –
2013 Q2
16 quarters
AAPL icon
13
Apple
AAPL
$5.01T
$69.9M 1.55%
1,940,460
-30,840
-2% -$1.14M
2016 Q1
5 quarters
PM icon
14
Philip Morris
PM
$320B
$68.7M 1.53%
585,230
– –
2013 Q2
16 quarters
ORLY icon
15
O'Reilly Automotive
ORLY
$70.1B
$67M 1.49%
4,595,490
-472,200
-9% -$7.71M
2013 Q2
16 quarters
CPRT icon
16
Copart
CPRT
$24.3B
$66.4M 1.48%
8,356,920
+36,960
+0.4% +$283K
2013 Q2
16 quarters
MDT icon
17
Medtronic
MDT
$121B
$65.8M 1.46%
741,555
+100
+0% +$8.43K
2016 Q3
3 quarters
LH icon
18
Labcorp
LH
$25.7B
$65.8M 1.46%
496,545
+1,845
+0.4% +$226K
2016 Q1
5 quarters
PARA icon
19
DELISTED
Paramount Global Class B
PARA
$64.2M 1.43%
1,006,570
-90
-0% -$5.76K
2015 Q3
7 quarters
NLSN
20
DELISTED
Nielsen Holdings plc
NLSN
$61.6M 1.37%
1,593,575
-235
-0% -$9.33K
2013 Q3
15 quarters
CB icon
21
Chubb
CB
$135B
$60.9M 1.35%
418,980
-19,990
-5% -$2.81M
2014 Q1
13 quarters
GILD icon
22
Gilead Sciences
GILD
$190B
$59.6M 1.32%
841,455
-80
-0% -$5.32K
2013 Q2
16 quarters
INTC icon
23
Intel
INTC
$519B
$57.8M 1.29%
1,714,345
+28,870
+2% +$1.03M
2017 Q1
1 quarter
CELG
24
DELISTED
Celgene Corp
CELG
$57.3M 1.27%
441,200
+9,285
+2% +$1.14M
2014 Q2
12 quarters
FTV icon
25
Fortive
FTV
$17.3B
$57.1M 1.27%
1,428,822
+9,277
+0.7% +$365K
2016 Q3
3 quarters
1
2 3 4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q2 2017 Portfolio in Review

As of Q2 2017, Nicholas Company held 225 positions worth $4.5B, up 2.2% from $4.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Company's Q2 2017 filing shows 17 new, 85 increased, 77 reduced and 10 closed positions. Its largest new stake was Keurig Dr Pepper: 216,925 shares worth $19.8M. The largest sale was DaVita, an estimated $42.1M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Nicholas Company's largest Q2 2017 buy was Keurig Dr Pepper: 216,925 shares worth $19.8M.
  • Nicholas Company added most to Fastenal in Q2 2017, an estimated $35.3M increase.
  • Nicholas Company's biggest Q2 2017 reduction was DaVita, cutting an estimated $42.1M.
  • Nicholas Company fully exited AbbVie in Q2 2017, selling an estimated $35.2M.
  • Nicholas Company's ten largest holdings make up 21% of its $4.5B portfolio in Q2 2017.
  • Nicholas Company opened 17 new positions and closed 10 in Q2 2017.
  • Nicholas Company's portfolio value rose 2.2% quarter-over-quarter to $4.5B.

Based on Nicholas Company's 13F filing for Q2 2017, filed 11 Aug 2017.